**Executive Summary**
This addendum, issued on April 30, 2026, by the National Pharmaceutical Pricing Authority (NPPA), amends Order No. 1583(E) dated March 25, 2026. The document updates the ceiling price fixation for scheduled formulation packs of I.V. fluids (non-glass with special features) by including a new manufacturer and specific brand names. It establishes restrictive pricing conditions for the added formulations, effective from the date of publication.
**Key Points / Main Content**
**Amendments to Table ‘B’**
* Serial number 38 is officially added to Table ‘B’ of the original order.
* The manufacturer identified in this addition is M/s Silica Healthcare Pvt. Ltd.
* The specific products/brand names included are "Euro Head" and "Euro Head Dual Port."
**Regulatory Clause Addition**
* A new clause, (g1), is inserted following clause (g).
* This clause specifies that for M/s Silica Healthcare Pvt. Ltd., ceiling prices are applicable only to the formulations listed at Sl. No. 2, 4, 5, and 7 of Table ‘A’.
**Impact Analysis**
**M/s Silica Healthcare Pvt. Ltd.**
**Impact**
The company’s "Euro Head" and "Euro Head Dual Port" I.V. fluid products are now regulated under the ceiling price fixation for scheduled formulations. Their pricing is specifically restricted to the formulations identified in Sl. No. 2, 4, 5, and 7.
**Action Required**
The manufacturer must ensure that the pricing of the specified formulations does not exceed the ceiling prices mandated by the NPPA in the original order and this addendum.
**National Pharmaceutical Pricing Authority (NPPA)**
**Impact**
The authority expands its regulatory oversight to include specific products from M/s Silica Healthcare Pvt. Ltd. under the price control framework for non-glass I.V. fluids.
**Action Required**
The NPPA must monitor compliance and ensure the manufacturer adheres to the specific pricing limitations set for the identified formulation numbers.
**Distributors and Retailers**
**Impact**
Stockists and retailers of "Euro Head" and "Euro Head Dual Port" brands are affected by the ceiling price regulations for the specified formulation packs.
**Action Required**
They must ensure that the retail price of the mentioned products does not exceed the ceiling price plus applicable taxes as per the pharmaceutical pricing guidelines.
Key Entities Referenced
National Pharmaceutical Pricing Authority (NPPA): The primary regulatory body under the Department of Pharmaceuticals responsible for fixing ceiling prices for scheduled drug formulations.
Order No. 1583(E): The referenced policy document regulating the ceiling price fixation of scheduled formulation packs of I.V. fluids (non-glass with special features).
M/s Silica Healthcare Pvt. Ltd.: The specific pharmaceutical manufacturer whose products are added to the list of regulated formulations under this addendum.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-02052026-272201
CG-DxLx-xEG-I0D2H0x5x2x0 26-272201
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 2087] नई दिल्ली, बृहस्ट्प जतर्ार, अप्रलै 30, 2026/र्िै ाख 10, 1948
No. 2087] NEW DELHI, THRUSDAY, APRIL 30, 2026/VAISAKHA 10, 1948
रसायन और उर्रव क मत्रं ालय
(औषध जर्भाग )
(राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण)
पररजिष्ट
नई दिल्ली, 30 अप्रलै , 2026
का.आ. 2168(अ).— भारत के असाधारण, रािपत्र में प्रकाजित, राष्ट्रीय औषध मूल्य जनधावरण प्राजधकरण के आिेि
संख्या 1583(अ) दिनांक 25 मार् व2026, िो दक आई.र्ी. के तरल पिार् व(जर्िेष सुजर्धाओं के सार् नॉन-ग्लास) के अनुसूजर्त
फॉर्मयुवलेिन पक्ै स के अजधकतम मूल्य जनधारव ण से संबंजधत ह ैको अब स ेजनम्नजलजखत िोड़कर पढा िाये:
(1) क्र. संख्या 38 को सारणी 'ख' में जनम्नानुसार िोड़ा िाएगा:
क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम
(1) (2) (3)
38. मेससव जसजलका हल्े र्केयर प्राइर्टे जलजमटेड (नीर् ेनोट छ1) यूरो हडे / यूरो हडे डुअल पोटव
3064 GI/2026 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(2) खडं (छ1) को खंड (छ) के बाि िोड़ा गया ह ैऔर इसे इस प्रकार पढा िाएगा:
“(छ1) सारणी 'ख' की क्रमांक संख्या 38 में उजल्लजखत मेससव जसजलका हल्े र्केयर प्राइर्ेट जलजमटेड के मामले म,े सारणी ‘क’
की केर्ल क्रमांक संख्या 2, 4, 5 और 7 मे जनर्िष्टव फॉमलूव ेिन की कीमतें लागू होती ह।ैं
[का.सं./277/145/2026/एफ़ / फा. स. ं 8(145)/2026/डीपी/एनपीपीए-जडर्ी-II]
भीर्ा राम यािर्, सहायक जनििे क
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ADDENDUM
New Delhi, the 30th April, 2026
S.O. 2168(E).— The National Pharmaceutical Pricing Authority’s Order No. 1583(E) dated 25.03.2026
published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation packs of I.V.
fluids (non-Glass with special features) is henceforth to be read with the following additions:
(1) Sl. No. 38 shall be added in Table ‘B’ as below:
Sl. No. Name of Manufacturer Product/ Brand Name
(1) (2) (3)
38. M/s Silica Healthcare Pvt. Ltd. (note g1 below) Euro Head / Euro Head Dual Port
(2) Clause (g1) is added after clause (g) & shall be read as follows:
“(g1) In case of M/s Silica Healthcare Pvt. Ltd. mentioned in Sl. No. 38 of Table B, only the prices of the formulations
specified at Sl. No. 2, 4, 5 & 7 are applicable”.
[PN/277/145/2026/F / F. No. 8(145)/2026/D.P./NPPA-Div.-II]
BHIVA RAM YADAV, Asstt. Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.